lamotrigine and cardiovascular agents

lamotrigine has been researched along with cardiovascular agents in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, P; Fan, Y; Lu, HC; Schulz, PE; Wang, YC; Xu, ZC1
Daniluk, J; Drop, B; Sawicka, KM; Szczyrek, M; Szpringer, M; Wawryniuk, A; Załuska, K; Załuska-Patel, K; Żółkowska, D; Łuszczki, JJ1

Other Studies

2 other study(ies) available for lamotrigine and cardiovascular agents

ArticleYear
Transient cerebral ischemia increases CA1 pyramidal neuron excitability.
    Experimental neurology, 2008, Volume: 212, Issue:2

    Topics: Animals; Cardiovascular Agents; Cell Death; Disease Models, Animal; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; Hippocampus; In Vitro Techniques; Ischemic Attack, Transient; Lamotrigine; Male; Membrane Potentials; Patch-Clamp Techniques; Pyramidal Cells; Pyrimidines; Rats; Statistics, Nonparametric; Triazines

2008
Ivabradine attenuates the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.
    Epilepsy research, 2017, Volume: 133

    Topics: Acetamides; Animals; Anticonvulsants; Benzazepines; Brain; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Epilepsy, Tonic-Clonic; Fructose; Ivabradine; Lacosamide; Lamotrigine; Male; Mice; Pregabalin; Topiramate; Triazines

2017